Hyundai invests $400,000 in pediatric cancer research at Augusta University
“We really rely on people like Hyundai who understand the need and give hope to these kids,” says David Munn, MD.
“We really rely on people like Hyundai who understand the need and give hope to these kids,” says David Munn, MD.
“This could positively impact care for children with brain tumors by improving their quality of life,” said Theodore Johnson, MD, PhD.
The University System of Georgia Board of Regents recently approved David C. Hess, MD, David Munn, MD, and Babak Baban, PhD, as the first three Augusta University faculty researchers to be named Regents’ Entrepreneurs for their success in translating research into a commercial setting to improve patient care.
The first in-human study of a new immunotherapy that blocks a natural enzyme that tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life, researchers say.